Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 14   

Articles published

APRI 1.97 +0.05 (2.60%)
price chart
Apricus Biosciences Lowered to Underperform at Zacks (APRI)
Apricus Biosciences, Inc, formerly NexMed, Inc, is a pharmaceutical research and development company focused on the design and development of products and technologies in multiple therapeutic areas, including oncology, sexual dysfunction, autoimmune ...
Market Movers � Netflix (NASDAQ:NFLX), Rite Aid Corporation (NYSE:RAD ...
Apricus Biosciences Inc (NASDAQ:APRI)'s stock in last trading day held volume of 94,535.00 shares as compared to its average volume of 120,764.00 shares.
Eye Catching Stocks : The Boeing Company (NYSE:BA), Trulia (NYSE:TRLA ...
Over the rest of the year, Apricus has announced that investors can continue to see launches throughout the rest of Europe and Canada.
Hot Watch List � VMware (NYSE:VMW), Marvell (NASDAQ:MRVL), Huntington ...
Apricus Biosciences, Inc. (NASDAQ:APRI) was downgraded by Zacks from a �neutral� rating to an �underperform� rating in a research note issued on Wednesday.
Related articles »  
Equities Research Analysts' Downgrades for July, 16th (APRI, ATLS, CRS, CVBF ...
Apricus Biosciences (NASDAQ:APRI) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. ... Yara International ASA (NASDAQ:YARIY) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.
Related articles »